- Home
- MTEN vs CELU Comparison
MTEN vs CELU Comparison
Compare MTEN & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEN
- CELU
- Stock Information
- Founded
- MTEN 2015
- CELU 2016
- Country
- MTEN China
- CELU United States
- Employees
- MTEN N/A
- CELU N/A
- Industry
- MTEN Building Products
- CELU Biotechnology: Pharmaceutical Preparations
- Sector
- MTEN Industrials
- CELU Health Care
- Exchange
- MTEN Nasdaq
- CELU Nasdaq
- Market Cap
- MTEN 36.9M
- CELU 42.2M
- IPO Year
- MTEN 2024
- CELU N/A
- Fundamental
- Price
- MTEN $5.52
- CELU $1.73
- Analyst Decision
- MTEN
- CELU
- Analyst Count
- MTEN 0
- CELU 0
- Target Price
- MTEN N/A
- CELU N/A
- AVG Volume (30 Days)
- MTEN 255.8K
- CELU 162.2K
- Earning Date
- MTEN 05-21-2025
- CELU 12-06-2024
- Dividend Yield
- MTEN N/A
- CELU N/A
- EPS Growth
- MTEN N/A
- CELU N/A
- EPS
- MTEN 0.13
- CELU N/A
- Revenue
- MTEN $9,136,855.00
- CELU $48,200,000.00
- Revenue This Year
- MTEN N/A
- CELU N/A
- Revenue Next Year
- MTEN N/A
- CELU $233.89
- P/E Ratio
- MTEN $43.81
- CELU N/A
- Revenue Growth
- MTEN 18.30
- CELU 225.94
- 52 Week Low
- MTEN $1.81
- CELU $1.00
- 52 Week High
- MTEN $9.87
- CELU $5.69
- Technical
- Relative Strength Index (RSI)
- MTEN N/A
- CELU 50.37
- Support Level
- MTEN N/A
- CELU $1.47
- Resistance Level
- MTEN N/A
- CELU $2.40
- Average True Range (ATR)
- MTEN 0.00
- CELU 0.22
- MACD
- MTEN 0.00
- CELU 0.05
- Stochastic Oscillator
- MTEN 0.00
- CELU 41.74
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.